查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1504193

e臨床解決方案的市場規模，佔有率，預測，趨勢分析:各產品，各終端用戶，不同階段-2031年前的全球預測

eClinical Solutions Market Size, Share, Forecast, & Trends Analysis by Product, End User, Phase - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 260 Pages | 商品交期: 5-7個工作天內

價格

電子臨床解決方案市場預計到 2031 年將達到 233.2 億美元，2024 年至 2031 年的複合年增長率為 13.9%。

基於徹底的二級和一級研究以及對市場情景的詳細分析，我們研究了關鍵的行業驅動因素、限制因素、課題、機會和趨勢。

電子臨床解決方案市場的成長主要是由醫療保健和生命科學產業產生的大量數據、臨床試驗數量不斷增加、支持臨床研究的努力以及對資金的需求不斷增加所推動的。來的增長。此外，大型連鎖醫院加強 IT 基礎設施的努力以及對精準醫療不斷增長的需求預計將為電子臨床解決方案市場的參與者提供成長機會。

目錄

第1章 概要

第2章 調查手法

第3章 摘要整理

第 4 章市場洞察

  • 摘要
  • 市場成長因素
    • 促進因素
      • 醫療保健和生命科學產業產生的大量數據
      • 臨床試驗數量增加
      • 支持臨床研究的舉措
    • 抑制因素
    • 支援電子臨床解決方案的基礎設施成本高昂
    • 機會
      • 增加對醫學和藥物研究的資助
      • 加強醫療保健領域基礎設施的舉措
      • 對精準醫療的需求不斷增加
    • 作業
      • 資料安全問題
      • 新興國家對資料系統的認知度較低
  • 趨勢
    • 人工智慧與機器學習的集成
    • 臨床試驗的分散化
  • 因素分析
  • 監理分析
  • 案例研究/使用範例

第五章電子臨床解決方案市場：依產品評估

  • 摘要
  • 臨床資料管理系統 (CDMS)
  • 臨床試驗管理系統 (CTMS)
  • 隨機/研究藥物供應管理系統
  • 電子資料收集 (EDC)
  • 電子臨床結果評估 (eCOA)
  • 電子病患報告結果 (ePRO)
  • 臨床分析平台
  • 電子臨床試驗主文件 (eTMF)
  • 臨床數據整合平台
  • 安全解決方案
  • 其他產品類型

第6章 e臨床解決方案市場:各臨床試驗階段評估

  • 概要
  • 階段I
  • 階段II
  • 階段III
  • 階段IV

第7章 e臨床解決方案市場:各終端用戶評估

  • 概要
  • 製藥·生物製藥企業
  • 臨床研究機關
  • 醫療設備廠商
  • 其他的終端用戶

第8章 e臨床解決方案市場:各地區評估

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 瑞士
    • 荷蘭
    • 瑞典
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 南美
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東·非洲

第9章 競爭分析

  • 概要
  • 主要成長策略
  • 競爭基準
  • 競爭儀表板
    • 產業領導者
    • 市場差異化要素
    • 領先企業
    • 新興企業
  • 主要企業的市場佔有率分析/市場排行榜(2023年)

第10章 企業簡介(產業概要，財務概要，產品系列，策略性展開，SWOT分析*)。

  • Dassault Systems S.E.
  • Fountayn
  • Merative L.P.
  • eClinical Solutions LLC
  • Clario(ERT and Bioclinica)
  • eClinicalWorks, LLC
  • IQVIA Inc.
  • Parexel International(MA)Corporation
  • MaxisIT Inc.
  • Signant Health
  • Castor
  • Veeva Systems Inc.
  • Oracle Corporation

(註*：僅提供前 5 名公司SWOT 分析)

第11章 附錄

Product Code: MRHC - 1041227

eClinical Solutions Market Size, Share, Forecast, & Trends Analysis by Product (CDMS, CTMS, eCOA, ePRO, eDC, eTMF, Clinical Analytics, Safety Solutions), End User (Pharmaceutical, Clinical Research Organization, Medical Device), Phase - Global Forecast to 2031

The eClinical solutions market is expected to reach $23.32 billion by 2031, at a CAGR of 13.9% from 2024 to 2031.

Following thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, opportunities, and trends.

The growth of the eClinical solutions market is primarily driven by the large amounts of data generated by the healthcare & life sciences industries, the growing number of clinical trials, initiatives supporting clinical research, and increasing funding for medical & pharmaceutical research & development. Moreover, IT infrastructure strengthening initiatives by large hospital chains, and the rising demand for precision medicine are expected to generate growth opportunities for the players operating in the eClinical solutions market.

Based on product, the eClinical solutions market is segmented into clinical data management systems (CDMS), clinical trial management systems (CTMS), randomization & trial supply management systems, electronic data capture (EDC), electronic clinical outcome assessments (eCOA), electronic patient-reported outcomes (ePRO), clinical analytics platforms, electronic trial master file (ETMF), clinical data integration platforms, safety solutions, and other product types. In 2024, the CDMS segment is expected to account for the largest share of 28.3% of the eClinical solutions market. The large market share of this segment is attributed to the increasing need to sort and manage the huge amount of data generated during clinical trials to gain valuable insights, and the large number of clinical trials performed each year. For instance, in 2022, 12,337 clinical trials were conducted in the Western Pacific, 13,066 in Europe, 11,935 in the Americas, 11,030 in Southeast Asia, 4,593 in the Eastern Mediterranean, and 861 in Africa (Source: World Health Organization).

Based on clinical trial phase, the eClinical solutions market is segmented into Phase I, Phase II, Phase III, and Phase IV. The Phase IV segment is expected to register the highest CAGR during the forecast period 2024-2031. The growth of this segment is attributed to the increasing importance of post-market surveillance, the growing use of real-world data and real-world evidence for the post-market surveillance of drugs, the growing number of drug approvals, and increasing R&D investments from pharmaceutical and biopharmaceutical companies.

Based on end user, the eClinical solutions market is segmented into pharmaceutical & biopharmaceutical companies, clinical research organizations, medical device manufacturers, and other end users. The clinical research organizations segment is expected to register the highest CAGR during the forecast period. The segment's growth is driven by pharmaceutical & biopharmaceutical companies' increasing outsourcing to clinical research organizations and their rising focus on R&D activities for drug discovery and development and the adoption of advanced technologies among CROs for clinical trial management.

An in-depth analysis of the geographical scenario of the eClinical solutions market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to account for the largest share of the global eClinical solutions market in 2024, followed by Europe and Asia-Pacific. Among the U.S. and Canada included in North America, in 2024, the U.S. is expected to account for the largest share of the eClinical solutions market in North America. The large market share of the U.S. is attributed to the presence of clinical trial sponsors, the high adoption of digital solutions in the pharmaceutical industry, the large number of clinical trials conducted each year, and the high adoption of eClinical solutions ranging from data management systems to analytics due to stringent regulatory requirements set by the U.S. FDA.

Key companies operating in the global eClinical solutions market are Dassault Systems S.E. (France), Fountayn (U.S.), Merative L.P. (U.S.), eClinical Solutions LLC (U.S.), Clario (U.S.), eClinicalWorks, LLC (U.S.), IQVIA Inc. (U.S.), Parexel International (MA) Corporation (U.S.), MaxisIT Inc. (U.S.), Signant Health (U.S.), Castor (U.S.), Veeva Systems Inc. (U.S.), and Oracle Corporation (U.S.).

Scope of the Report:

eClinical Solutions Market Assessment-by Product

  • Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS)
  • Randomization & Trial Supply Management Systems
  • Electronic Data Capture (EDC)
  • Electronic Clinical Outcome Assessments (eCOA)
  • Electronic Patient-reported Outcomes (ePRO)
  • Clinical Analytics Platforms
  • Electronic Trial Master File (eTMF)
  • Clinical Data Integration Platforms
  • Safety Solutions
  • Other Product Types

(Note: Other product types include regulatory information management systems, electronic consent solutions, and institutional review board systems.)

eClinical Solutions Market Assessment-by Clinical Trial Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

eClinical Solutions Market Assessment-by End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Clinical Research Organizations
  • Medical Device Manufacturers
  • Other end Users

(Note: Other end users include consulting companies, academic & research institutes, and hospitals.)

eClinical Solutions Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Switzerland
    • Sweden
    • Netherlands
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Overview

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Data Collection & Validation Process
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
  • 2.3. Market Sizing & Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Drivers
      • 4.2.1.1 Large Amounts of Data Generated from the Healthcare & Lifesciences Industries
      • 4.2.1.2. Growing Number of Clinical Trials
      • 4.2.1.3. Initiatives Supporting Clinical Research
    • 4.2.2. Restraints
    • 4.22.1. High Costs of Supporting Infrastructure for eClinical Solutions
    • 4.2.3. Opportunities
      • 4.2.3.1. Growing Funding for Medical & Pharmaceutical Research
      • 4.2.3.2. Infrastructure Strengthening Initiatives in the Healthcare Sector
      • 4.2.3.3. Growing Demand for Precision Medicine
    • 4.2.4. Challenges
      • 4.2.4.1. Data Security Concerns
      • 4.2.4.2. Low Awareness Regarding Data Systems in Developing Countries
  • 4.3. Trends
    • 4.3.1. Integration of Artificial Intelligence and Machine Learning
    • 4.3.2. Decentralized Clinical Trials
  • 4.4. Factors Analysis
  • 4.5. Regulatory Analysis
  • 4.6. Case Studies/Use Cases

5. eClinical Solutions Market Assessment-by Product

  • 5.1. Overview
  • 5.2. Clinical Data Management Systems (CDMS)
  • 5.3. Clinical Trial Management Systems (CTMS)
  • 5.4. Randomization & Trial Supply Management Systems
  • 5.5. Electronic Data Capture (EDC)
  • 5.6. Electronic Clinical Outcome Assessments (eCOA)
  • 5.7. Electronic Patient-reported Outcomes (ePRO)
  • 5.8. Clinical Analytics Platforms
  • 5.9. Electronic Trial Master File (eTMF)
  • 5.10. Clinical Data Integration Platforms
  • 5.11. Safety Solutions
  • 5.12. Other Product Types

6. eClinical Solutions Market Assessment-by Clinical Trial Phase

  • 6.1. Overview
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. eClinical Solutions Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Pharmaceutical & Biopharmaceutical Companies
  • 7.3. Clinical Research Organizations
  • 7.4. Medical Device Manufacturers
  • 7.5. Other End Users

8. eClinical Solutions Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Switzerland
    • 8.3.7. Netherlands
    • 8.3.8. Sweden
    • 8.3.9. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. India
    • 8.4.3. Japan
    • 8.4.4. South Korea
    • 8.4.5. Australia
    • 8.4.6. Rest of Asia-Pacific
  • 8.5. Latin America
  • 8.6. Brazil
  • 8.7. Mexico
  • 8.8. Rest of Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share Analysis/Market Rankings of Key Players (2023)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

  • 10.1. Dassault Systems S.E.
  • 10.2. Fountayn
  • 10.3. Merative L.P.
  • 10.4. eClinical Solutions LLC
  • 10.5. Clario (ERT and Bioclinica)
  • 10.6. eClinicalWorks, LLC
  • 10.7. IQVIA Inc.
  • 10.8. Parexel International (MA) Corporation
  • 10.9. MaxisIT Inc.
  • 10.10. Signant Health
  • 10.11. Castor
  • 10.12. Veeva Systems Inc.
  • 10.13. Oracle Corporation

(Note*: SWOT analysis will be provided for the top 5 companies.)

11. Appendix

  • 11.1. Available Customization
  • 12.2. Related Reports

LIST OF TABLES

  • Table 1 Global eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 2 Global Clinical Data Management Systems (CDMS) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 3 Global Clinical Trial Management Systems (CTMS) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Randomization & Trial Supply Management Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 5 Global Electronic Data Capture (EDC) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global Electronic Clinical Outcome Assessments (eCOA) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 7 Global Electronic Patient-reported Outcomes (ePRO) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global Clinical Analytics Platforms Market, by Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Electronic Trial Master File (eTMF) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 10 Global Clinical Data Integration Platforms Market, by Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Safety Solutions Market, by Country/Region, 2022-2031 (USD Million)
  • Table 12 Global Other eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
  • Table 13 Global eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 14 Global eClinical Solutions Market for Phase I, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global eClinical Solutions Market for Phase II, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global eClinical Solutions Market for Phase III, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global eClinical Solutions Market for Phase IV, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 19 Global eClinical Solutions Market for Pharmaceutical & Biopharmaceutical Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global eClinical Solutions Market for Clinical Research Organizations, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global eClinical Solutions Market for Medical Device Manufacturers, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global eClinical Solutions Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 North America: eClinical Solutions Market, by Country, 2022-2031 (USD Million)
  • Table 25 North America: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 26 North America: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 27 North America: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 28 U.S.: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 29 U.S.: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 30 U.S.: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 31 Canada: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 32 Canada: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 33 Canada: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 34 Europe: eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
  • Table 35 Europe: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 36 Europe: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 37 Europe: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 38 Germany: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 39 Germany: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 40 Germany: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 41 France: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 42 France: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 43 France: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 44 U.K.: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 45 U.K.: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 46 U.K.: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 47 Italy: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 48 Italy: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 49 Italy: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 50 Spain: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 51 Spain: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 52 Spain: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 53 Switzerland: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 54 Switzerland: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 55 Switzerland: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 56 Sweden: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 57 Sweden: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 58 Sweden: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 59 Netherlands: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 60 Netherlands: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 61 Netherlands: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 62 Rest of Europe: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 63 Rest of Europe: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 64 Rest of Europe: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 65 Asia-Pacific: eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
  • Table 66 Asia-Pacific: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 67 Asia-Pacific: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 68 Asia-Pacific: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 69 China: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 70 China: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 71 China: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 72 India: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 73 India: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 74 India: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 75 Japan: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 76 Japan: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 77 Japan: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 78 South Korea: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 79 South Korea: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 80 South Korea: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 81 Australia: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 82 Australia: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 83 Australia: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 84 Rest of Asia-Pacific: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 85 Rest of Asia-Pacific: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 86 Rest of Asia-Pacific: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 87 Latin America: eClinical Solutions Market, by Country/Region, 2022-2031 (USD Million)
  • Table 88 Latin America: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 89 Latin America: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 90 Latin America: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 91 Brazil: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 92 Brazil: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 93 Brazil: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 94 Mexico: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 95 Mexico: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 96 Mexico: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 97 Rest of Latin America: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 98 Rest of Latin America: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 99 Rest of Latin America: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 100 Middle East & Africa: eClinical Solutions Market, by Product, 2022-2031 (USD Million)
  • Table 101 Middle East & Africa: eClinical Solutions Market, by Clinical Trial Phase, 2022-2031 (USD Million)
  • Table 102 Middle East & Africa: eClinical Solutions Market, by End User, 2022-2031 (USD Million)
  • Table 103 Recent Developments, by Company, 2021-2024

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for the Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Sizing & Growth Forecast Approach
  • Figure 7 Global eClinical Solutions Market, by Product, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global eClinical Solutions Market, by Clinical Trials Phase, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global eClinical Solutions Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global eClinical Solutions Market, by Geography
  • Figure 11 Impact Analysis of Market Dynamics
  • Figure 12 Global eClinical Solutions Market, by Product, 2024 Vs. 2031 (USD Million)
  • Figure 13 Global eClinical Solutions Market, by Clinical Trials Phase, 2024 Vs. 2031 (USD Million)
  • Figure 14 Global eClinical Solutions Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 15 Global eClinical Solutions Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 16 North America: eClinical Solutions Market Snapshot
  • Figure 17 Europe: eClinical Solutions Market Snapshot
  • Figure 18 Asia-Pacific: eClinical Solutions Market Snapshot
  • Figure 19 Latin America: eClinical Solutions Market Snapshot
  • Figure 20 Key Growth Strategies Adopted by Leading Players (2021-2024)
  • Figure 21 eClinical Solutions Market: Competitive Benchmarking, by Product
  • Figure 22 eClinical Solutions Market: Competitive Benchmarking, by Region
  • Figure 23 eClinical Solutions Market: Competitive Dashboard
  • Figure 24 Global eClinical Solutions Market Share Analysis/Market Rankings of Key Players, (2023)
  • Figure 25 Dassault Systems S.E.: Financial Overview (2023)
  • Figure 26 IQVIA Inc.: Financial Overview (2023)
  • Figure 27 Veeva Systems Inc.: Financial Overview (2023)
  • Figure 28 Oracle Corporation: Financial Overview (2023)